Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2013 Oct;30(4):277-9.
doi: 10.4103/0970-2113.120599.

Prevalence of multidrug resistance among retreatment pulmonary tuberculosis cases in a tertiary care hospital, Hyderabad, India

Subhakar Kandi  1 , Surapaneni Venkateswara Prasad, P Navaneeth Sagar Reddy, Vennaposa Chenna Kishore Reddy, Rajya Laxmi, Dhanamurthy Kopuu, Kiran Kumar Kondapaka, M S Sreenivas Rao, P H Vishnu
Affiliations

Prevalence of multidrug resistance among retreatment pulmonary tuberculosis cases in a tertiary care hospital, Hyderabad, India

Subhakar Kandi et al. Lung India. 2013 Oct.

Abstract

Background: India is one of the high tuberculosis (TB) burden countries in the world. India ranks second in harboring multi drug resistant (MDR)-TB cases. About 50,000 of MDR cases are recorded in retreatment pulmonary TB cases. This study was conducted in a tertiary care facility (Government General and Chest Hospital) in Hyderabad, India.

Objectives: TOASSESS: Proportion of the TB patients having MDR-TB at the initiation of retreatment regimen; the prevalence of isoniazid (INH) resistance in this geographical area.

Materials and methods: An analytical, observational, prospective cohort study of patients attending the out-patient department from December 2010 to March 2011.

Results: Sputum samples from 100 patients were subjected to acid fast bacilli (AFB) culture and drug sensitivity testing. Of these, 28 (28%) were MDR-TB, 42 (42%) were non-MDR-TB and 39% being INH resistance.

Conclusions: In conclusion, one third of the retreatment pulmonary TB cases attending a tertiary care institute for TB will be MDR-TB at the initiation of treatment and there is a need to include ethambutol in the continuation phase of new TB case treatment in view of high INH resistance.

Keywords: Category IV (category four); India; directly observed treatment; multidrug resistant tuberculosis; retreatment cases; short-course plus (DOTS plus).

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest: None declared.

Figures

Figure 1
Figure 1
Prevalence drug resistance among retreatment pulmonary tuberculosis patients, inGovernment General and Chest Hospital, Hyderabad, India. *Contaminated samples are recollected within 1 week of the result
Figure 2
Figure 2
Individual drug resistance patterns includes individual and combined resistance in retreatment pulmonary tuberculosis patients
See this image and copyright information in PMC

References

    1. Geneva: World Health Organisation; 2010. World Health Organisation. WHO Report on global tuberculosis control: Epidemiology, strategy, financing.
    1. World Health Organisation. [Last accessed on 2011 Sep 13]. Available from: http://www.who.int/tb/data .
    1. Central Tuberculosis Division. Technical and operational guidelines for tuberculosis control, revised National Tuberculosis Control Programme. Government of India: Directorate General of Health Services, Ministry of Health and Family Welfare. 2005
    1. World Health Organization. [Last accessed on 2012 Jun 12]. Available from: http://www.whoindia.org/en/section3/section123.htm .
    1. TBC India. [Last accessed on 2011 Sep 15]. Available from: http://www.tbcindia.org/rntcpasp .